NantKwest Chairman & CEO Dr. Patrick Soon-Shiong Exercises $39 Million in Warrants and Options in Support of NK’s Natural Killer Cell Strategic Vision Beyond Check Point Immunotherapy
Go back to NantKwest Chairman & CEO Dr. Patrick Soon-Shiong Exercises $39 Million in Warrants and Options in Support of NK’s Natural Killer Cell Strategic Vision Beyond Check Point Immunotherapy| (NASDAQ: NK) | Delayed: 32.49 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.49 | 52 Week High | $18.74 | |||
| Open | $6.52 | 52 Week Low | $5.43 | |||
| Day High | $32.49 | P/E | N/A | |||
| Day Low | $32.49 | EPS | $0.00 | |||
| Volume | 354,843 | |||||
